Researchers at the University of California at San Diego have identified a new molecular target for influenza drugs and have also found drugs already approved by the U.S. Food and Drug Administration that just might perfectly hit the target (neuraminidase, one of two major proteins present on the surface of the influenza virust that allows newly replicated viruses to be released into their host).